Cipla acquires anti-infective ZEMDRI drug from Achaogen

Cipla acquires anti-infective ZEMDRI drug from Achaogen

11:19 AM, 26th July 2019
Cipla logo

WARREN, NEW JERSEY/MUMBAI, INDIA: Cipla USA Inc has acquired prescription drug ZEMDRI (Plazomicin) from Achaogen Inc. The company has acquired worldwide rights of ZEMDRI (excluding Greater China) with its allied assets and limited liabilities.

ZEMDRI is a once-daily novel intravenous (IV) aminoglycoside for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, in adults who are unresponsive to currently available treatment options.

ZEMDRI was approved by the United States Food & Drug Administration (USFDA) in June 2018, and was launched in the same year, with patent protection expected to continue until 2031 or 2032.

ZEMDRI is the latest milestone in Cipla’s history of proactive and humanitarian leadership in enabling access to life-saving drugs.

“The acquisition of ZEMDRI deepens our pipeline of specialty products in US in our identified focus areas of central nervous system, lung delivery of medicines, and institutionally administered products. With a robust front-end commercial infrastructure for US hospital sales in place, we expect to extract strong synergy from our IV Plazomicin and IV Tramadol assets,” said Umang Vohra, Managing Director and Global Chief Executive Officer, Cipla.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Bostik to acquire thermobonding films manufacturer Prochimir

COLOMBES, FRANCE: Bostik, an Arkema company said that it will acquire Prochimir, a company specializing in high performance thermobonding adhesive fil ...

Read more
Clariant helps packaging customers protect & improve quality of recycled polymers

MUTTENZ, SWITZERLAND: Clariant Masterbatches and its Packaging Market group, said that it is mobilizing considerable resources to help ensure that an ...

Read more
Covestro starts up new thermoplastic composites’ investments

LEVERKUSEN, GERMANY: Covestro AG said that it is further developing its offerings and capabilities in continuous fibre-reinforced thermoplastic (CFRTP ...

Read more
AZeotropy: India’s Largest symposium for chemical engineering students

India is a country with the largest number of students pursuing engineering. A common platform where students from various parts of the country can ch ...

Read more
Clariant expands facility in India, adds new desiccant packet capability

MUTTENZ, SWITZERLAND: The Clariant Healthcare Packaging business unit said that it is now producing desiccant packets at its plant in Cuddalore, Tamil ...

Read more
McDermott bags technology contract for Indian Oil’s FCC unit

HOUSTON, US: McDermott International Inc has been awarded a sizeable technology contract by Indian Oil Corporation Limited (IOCL). Award includes ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X